GILD vs UTHR
Gilead Sciences vs United Therapeutics — AI-powered side-by-side comparison
| Metric | GILD | UTHR |
|---|---|---|
| AI Score | 55 | 70 |
| Price | $133.10 | $538.75 |
| P/E Ratio | -51.23× | 17.82× |
| ROE | 37.5% | 18.8% |
| Revenue Growth YoY | — | — |
| Gross Margin | 79.6% | 86.1% |
| Debt / Equity | 0.21× | 0.00× |
| Dividend Yield | 2.4% | 0.0% |
| RSI (14) | 54.4 | 66.9 |
| Beta | 0.343 | 0.58 |
| Expected Upside | +18.2% | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
UTHR Full Analysis